Gain Therapeutics, Inc. (GANX): Shareholders' Equity
$18.56M
As of 2025-12-31
$11.29M
As of 2026-06-30
-0.6%
3-year compound annual growth
+24.5%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.56M | +152.9% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $7.34M | -41.6% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $12.58M | -33.4% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $18.88M | -45.8% | 2024-03-26, Balance as of period end |
| 2021-12-31 | $34.82M | +461.4% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $6.20M | n/a | 2022-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $18.56M | +152.9% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $18.22M | -53.5% |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $18.59M | -51.6% |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | $15.01M | +33.9% |
| BriaCell Therapeutics Corp. (BCTX) | 2025-07-31 | $17.33M | n/m |
| Immunic, Inc. (IMUX) | 2025-12-31 | -$6.67M | n/m |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | $16.92M | -68.9% |
| Phio Pharmaceuticals Corp. (PHIO) | 2025-12-31 | $20.15M | +326.6% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $16.13M | -37.4% |
Compare GANX, CRVO, FTH, MBRX side by side · Screen every company in Pharmaceutical Preparations ↗